Remove Genetics Remove Pharma Companies Remove Production
article thumbnail

GSK turns to AI specialist Tempus for R&D productivity boost

pharmaphorum

One of the first actions by GSK’s recently appointed chief scientific officer, Tony Wood, has been to expand a partnership with Tempus aimed at improving the big pharma’s R&D productivity, starting with its cancer pipeline. The post GSK turns to AI specialist Tempus for R&D productivity boost appeared first on.

article thumbnail

op Pharma Marketing Trends Shaping the Future of Healthcare in 2025

Pharma Marketing Network

Moreover, the adoption of digital tools like mobile apps and telemedicine platforms is facilitating direct communication between pharma companies and end-users. As patients become more digitally savvy, pharma companies are investing in creating seamless digital experiences that cater to their needs and preferences.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Tapping into pharma’s growing opportunities in digital health

Pharmaceutical Technology

In addition to doing more to proactively support healthcare providers and patients, digital health opportunities provide a chance for pharma companies to capture (and become a trusted source of) important real-world data about patients’ behaviour and their wider wellbeing. Breaking down the opportunities.

article thumbnail

Ipsen plans sale of consumer health business for €350m

pharmaphorum

Ipsen has started exclusive negotiations that could see its global consumer health business sold to fellow French pharma company Mayoly Spindler later this year. billion takeover of Clementia Pharma in 2019. billion takeover of Clementia Pharma in 2019. billion of its revenues last year.

Sales 103
article thumbnail

A realistic view of healthcare in 2022

World of DTC Marketing

Studies show that tens of millions of dollars are being wasted due to fraud with programmatic advertising, but many pharma companies are still wasting money on the channel. Invest in product websites with content and usability studies. Digital, within healthcare, is used differently by online health seekers.

Marketing 244
article thumbnail

Building early relationships: a gamechanger for pioneering rare disease treatment

pharmaphorum

One group excelling in this space is the Genetic Alliance. Their work ranges from developing new services in partnership with the National Health Service (NHS) to working with the All Party Parliamentary Group on Rare, Genetic and Undiagnosed Conditions, and the Department of Health on the UK Strategy for Rare Diseases.

article thumbnail

Alzheimer’s Research UK starts AI-based drug hunt with Exscientia

pharmaphorum

UK biotech Exscientia has signed a string of partnerships with pharma companies and other research-based organisations to apply its AI-based drug discovery platform. It reckons its use of AI and machine learning can trim years off the current 12- to 15-year cycle from early research to marketed product.

Research 119